컨텐츠 내용을 수정할 수 있습니다
The menstrual cycle is controlled by the hypothalamic–pituitary–ovarian axis. Gonadotropin-releasing hormone (GnRH) from the hypothalamus stimulates the anterior pituitary to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The ovary and the endometrium change in parallel.
| Phase | Ovary | Endometrium | Dominant hormones |
|---|---|---|---|
| Menstrual (days 1–5) | New follicles recruited | Functional layer sheds | Estrogen and progesterone low |
| Follicular (day 1 to ovulation) | FSH gradually rises and matures follicles; dominant follicle secretes estrogen | Proliferative phase — estrogen thickens the lining | Rising estrogen |
| Ovulation (about 14 days before the next period) | LH surge releases the oocyte | — | LH peak, estrogen peak |
| Luteal (ovulation to menses) | Corpus luteum secretes progesterone | Secretory phase — glands and blood supply prepare for implantation | Progesterone high |
| Disorder | Definition / key mechanism |
|---|---|
| Primary amenorrhea | No menses by age 15 with secondary sex characteristics (or no breast development by 13) |
| Secondary amenorrhea | No menses for 3 months with previously regular cycles, or 6 months with irregular cycles. Pregnancy is the most common cause |
| Abnormal uterine bleeding (AUB) | Bleeding abnormal in frequency, regularity, duration, or volume. Causes classified by PALM-COEIN: Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia (structural); Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not yet classified |
| Heavy menstrual bleeding | Excessive blood loss that interferes with quality of life (older definition: > 80 mL per cycle or > 7 days) |
| Frequent menstrual bleeding | Cycles shorter than 24 days — evaluate for structural causes (polyp, submucosal fibroid, adenomyosis) and ovulatory dysfunction |
| Primary dysmenorrhea | Painful menses without pelvic pathology; excess prostaglandins cause uterine contractions and ischemia; begins with ovulatory cycles in adolescence |
| Secondary dysmenorrhea | Pain from pelvic pathology — endometriosis, adenomyosis, fibroids, PID |
| Premenstrual syndrome (PMS) | Physical and emotional symptoms in the luteal phase that resolve within a few days after menses starts |
| Premenstrual dysphoric disorder (PMDD) | Severe mood symptoms (irritability, depression, anxiety) causing marked impairment; a depressive disorder in DSM-5-TR |
| Polycystic ovary syndrome (PCOS) | Ovulatory dysfunction, hyperandrogenism, and polycystic ovaries; strongly linked to insulin resistance |
| Hyperprolactinemia | Prolactin suppresses GnRH → amenorrhea, galactorrhea; prolactinoma, hypothyroidism, antipsychotics |
| Functional hypothalamic amenorrhea | Low energy availability, weight loss, intense exercise, stress — part of the female athlete triad (low energy availability, menstrual dysfunction, low bone density) |
| Drug / class | Use | Key safety points |
|---|---|---|
| NSAIDs (ibuprofen, naproxen, mefenamic acid) | First-line for primary dysmenorrhea; also reduce heavy bleeding | Start at onset of menses or pain (or 1–2 days before) and take on schedule for 2–3 days; take with food. GI bleeding, kidney injury, raised blood pressure; avoid with peptic ulcer, kidney disease, aspirin/NSAID-sensitive asthma, anticoagulants, and pregnancy from 20 weeks (avoid in the third trimester) |
| Combined hormonal contraceptives | Dysmenorrhea, heavy bleeding, PCOS, PMS/PMDD (drospirenone–ethinyl estradiol) | Contraindicated with smoking at age 35 or older, history of VTE or stroke, migraine with aura, uncontrolled hypertension, breast cancer, liver disease. Teach ACHES warning signs (Abdominal pain, Chest pain, Headaches, Eye problems, Severe leg pain). Drospirenone can raise potassium — caution with kidney or adrenal disease and with potassium-sparing diuretics, ACE inhibitors, or ARBs |
| Levonorgestrel IUD | Most effective medical treatment for heavy menstrual bleeding | Irregular spotting early; rare perforation or expulsion |
| Tranexamic acid | Heavy bleeding — taken only during menses (up to 5 days) | Antifibrinolytic — contraindicated with active or past thromboembolism; caution with combined hormonal contraceptives |
| Progestins (oral or injectable) | Ovulatory dysfunction; endometrial protection | Irregular bleeding, mood change, weight gain; injectable medroxyprogesterone causes reversible bone loss |
| SSRIs (fluoxetine, sertraline, paroxetine) | First-line drug for PMDD; continuous or luteal-phase dosing | Nausea, sexual dysfunction, insomnia; suicidality warning in young people; serotonin syndrome risk with other serotonergic drugs |
| Metformin | PCOS with insulin resistance | GI upset, lactic acidosis risk with kidney impairment |
| Letrozole | First-line ovulation induction in PCOS (off-label) | Rule out pregnancy before each cycle and stop if pregnant; hot flashes, dizziness, fatigue; monitor for multiple pregnancy |
| Dopamine agonists (cabergoline, bromocriptine) | Hyperprolactinemia / prolactinoma — first-line even for most macroadenomas | Nausea, orthostatic hypotension (take at bedtime with food), impulse-control changes; cabergoline at high doses — cardiac valve disease |
| Iron (oral) | Iron-deficiency anemia | Best absorbed on an empty stomach with vitamin C; take with food if GI upset; separate from dairy, calcium, antacids, tea/coffee; dark stools, constipation |
Procedures — hysteroscopic removal of polyps or submucosal fibroids; endometrial ablation for heavy bleeding when childbearing is complete; hysterectomy as definitive therapy.
Acute heavy bleeding with instability — IV access, fluids, type and crossmatch, transfusion as needed; high-dose IV or oral hormones or tranexamic acid per provider; rarely uterine tamponade or curettage.
Listed in priority order.
| Complication | Warning signs | Priority action |
|---|---|---|
| Hemorrhage / hypovolemia | Tachycardia, hypotension, dizziness, syncope, soaking pads hourly | Lie flat, IV access, notify provider, CBC and type and crossmatch |
| Iron-deficiency anemia | Fatigue, pallor, dyspnea, low hemoglobin and ferritin | Iron replacement; treat cause |
| Ectopic pregnancy mimicking menstrual pain | Missed period, unilateral pelvic pain, spotting, shoulder pain, shock | hCG and ultrasound; emergency if unstable |
| Ovarian cyst rupture or torsion | Sudden unilateral pain (torsion: severe pain with nausea and vomiting) | Urgent evaluation — torsion is a surgical emergency |
| Toxic shock syndrome | Fever, rash, hypotension, multiorgan signs | Remove tampon, sepsis care |
| Bone loss / stress fractures | Prolonged hypothalamic amenorrhea, low weight | Restore energy balance, DXA, calcium and vitamin D |
| Endometrial hyperplasia or cancer | Chronic anovulation (PCOS, obesity) with prolonged unopposed estrogen | Endometrial sampling; progestin protection |
| Suicidality in PMDD | Hopelessness, self-harm talk | Safety assessment, urgent mental health referral |
다음 이론을 계속 학습하려면 로그인하세요.
로그인하고 계속 학습필기노트, 하이라이터, 메모는 잘 쓰고 있어?
내보내줘운영진이 검토할게요!
마이페이지에서 차단한 회원을 관리할 수 있어요.